CA
DMAC icon

Cliff Asness’s DiaMedica Therapeutics DMAC Stock Holding History

Cliff Asness’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78.3K Sell
11,127
-160
-1% -$983 ﹤0.01% 3869
2026
Q1 		$76.4K Sell
11,287
-24,478
-68% -$194K ﹤0.01% 3697
2025
Q4 		$285K Buy
35,765
+8,314
+30% +$62.2K ﹤0.01% 3200
2025
Q3 		$189K Buy
+27,451
New +$149K ﹤0.01% 3271

Other funds holding DMAC

CLG
Cooperman Leon G $3.55B AUM 41.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Cliff Asness's DMAC Position: Q2 2026 in Review

Cliff Asness reduced its DiaMedica Therapeutics (DMAC) stake by 1.4% in Q2 2026, selling an estimated $983 and leaving 11,127 shares worth $78.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3869.

Cliff Asness first reported a position in DMAC in Q3 2025 and has held it in 4 quarters since. The position peaked at $285K in Q4 2025. 88 funds tracked by Wall St. Rank hold DMAC as of Q2 2026.

  • Cliff Asness held 11,127 shares of DiaMedica Therapeutics worth $78.3K as of Q2 2026.
  • Cliff Asness sold 160 DiaMedica Therapeutics shares in Q2 2026, an estimated $983.
  • DiaMedica Therapeutics made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #3869 holding.
  • Cliff Asness first reported a position in DiaMedica Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Cliff Asness's DiaMedica Therapeutics position peaked at $285K in Q4 2025.
  • 88 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.